Literature DB >> 25765354

Differential expression of interferon alpha inducible genes in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus and healthy donors.

Sonya A MacParland1, Christopher P Corkum1, Christopher Burgess2, Sylwia Karwowska2, Werner Kroll2, Tomasz I Michalak3.   

Abstract

The impact of exposure to interferon-alpha (IFN-α) on gene expression in peripheral blood mononuclear cells (PBMC) from hepatitis C virus (HCV)-infected and healthy individuals was investigated to recognize whether their PBMC differ in expression of IFN-inducible genes (ISGs) following treatment with IFN-α2b. PBMC obtained from healthy and treatment-naïve HCV-infected patients were cultured with IFN-α2b for 30min, 2h, 4h and 72h, and gene expression was analyzed using mRNA microarray technology. IFN-α caused differential up-regulation of many known ISGs in PBMC from both HCV-infected and healthy subjects. In comparison to untreated controls, the highest augmentation in PBMC ISG expression occurred after 4-hour exposure to IFN-α2b in both groups. The analysis identified 84 transcripts, representing 64 known and 2 unknown genes, that were up-regulated by at least 5-fold in PBMC from infected and uninfected individuals. However, the expression of IFN-α inducible genes was impaired in the PBMC from HCV-infected individuals compared to healthy controls. This was due to an increased baseline expression of the transcripts in PBMC of HCV-infected patients. These findings expand our understanding of IFN-responses in HCV-infected individuals and suggest that functions of PBMC, which include immune effector cells, are altered in patients chronically infected with HCV.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic hepatitis C virus infection; Interferon alpha therapy; Interferon alpha-induced gene expression; Peripheral blood mononuclear cells

Mesh:

Substances:

Year:  2015        PMID: 25765354     DOI: 10.1016/j.intimp.2015.02.037

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

1.  USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study.

Authors:  Sona Frankova; Milan Jirsa; Dusan Merta; Magdalena Neroldova; Petr Urbanek; Renata Senkerikova; Julius Spicak; Jan Sperl
Journal:  Ther Clin Risk Manag       Date:  2015-12-17       Impact factor: 2.423

2.  Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro.

Authors:  Georgia Skardasi; Annie Y Chen; Tomasz I Michalak
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

3.  Analysis of TLR7, SOCS1 and ISG15 immune genes expression in the peripheral blood of responder and non-responder patients with chronic Hepatitis C.

Authors:  Razieh Dowran; Jamal Sarvari; Afagh Moattari; Mohammad-Reza Fattahi; Amin Ramezani; Seyed Younes Hosseini
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.